Function	FDR	Genes in network	Genes in genome
stem cell population maintenance	5.579864047810821e-11	10	70
maintenance of cell number	3.443415268819349e-10	10	89
pattern specification process	1.0059245927025185e-7	11	223
embryo development ending in birth or egg hatching	1.922461185821948e-7	10	182
chordate embryonic development	1.922461185821948e-7	10	179
DNA-binding transcription repressor activity	2.0430544467724313e-7	11	254
regionalization	9.507127433877388e-7	9	157
Notch signaling pathway	0.000027049391178668394	7	103
epithelial to mesenchymal transition	0.000033491868923756354	7	108
aorta morphogenesis	0.000040704967177975074	4	12
artery morphogenesis	0.000040704967177975074	5	32
cardiac ventricle development	0.00005820325792928226	6	71
regulation of Notch signaling pathway	0.00006359798748554602	6	73
mesenchyme morphogenesis	0.00008774246366668635	5	39
cardiac chamber morphogenesis	0.00008890156491586964	6	79
artery development	0.0001127435616780154	5	42
mesenchyme development	0.00012321996990177005	8	216
cardiac chamber development	0.00018702789136745878	6	93
aorta development	0.00018702789136745878	4	19
cell fate commitment involved in formation of primary germ layer	0.00021566579691437328	4	20
heart development	0.0003145276300143472	8	251
cell surface receptor signaling pathway involved in heart development	0.000426586176880937	4	24
mesenchymal cell differentiation	0.000526598071447949	7	185
ventricular septum development	0.0006419963004076166	4	27
cell fate specification	0.0007176063726238056	4	28
embryonic morphogenesis	0.0008819058894095643	8	296
smooth muscle cell differentiation	0.0008858088474118641	4	30
endocardial cushion development	0.0012678247276499994	4	33
segmentation	0.001384563476343845	4	34
PcG protein complex	0.0015081063156591385	4	35
in utero embryonic development	0.001638626871813894	4	36
regulation of epithelial cell proliferation	0.0016644140492648022	7	232
heart morphogenesis	0.0016644140492648022	6	148
semi-lunar valve development	0.001671809161204789	4	37
G0 to G1 transition	0.002171852224470301	4	40
regulation of G0 to G1 transition	0.002171852224470301	4	40
cardiac septum morphogenesis	0.0028365567547692884	4	43
blood vessel endothelial cell migration	0.0029034098098232606	5	95
positive regulation of DNA metabolic process	0.003322117224361839	6	174
heart valve morphogenesis	0.003322117224361839	4	46
epithelial cell proliferation	0.003322117224361839	7	266
muscle tissue morphogenesis	0.003322117224361839	4	46
muscle organ morphogenesis	0.003499689825426422	4	47
endodermal cell differentiation	0.003500896149318703	3	15
atrioventricular valve morphogenesis	0.003500896149318703	3	15
heart trabecula morphogenesis	0.003500896149318703	3	15
heart valve development	0.003788307850698354	4	49
anterior/posterior pattern specification	0.004023931742620517	4	50
axis specification	0.004268788776440418	4	51
embryonic organ development	0.0044343431611002055	6	189
cardiac ventricle morphogenesis	0.0044343431611002055	4	52
pulmonary valve development	0.004440047705567841	3	17
positive regulation of cyclin-dependent protein kinase activity	0.004440047705567841	3	17
endocardial cushion formation	0.004440047705567841	3	17
embryonic placenta development	0.005128001389629618	3	18
angiogenesis	0.005128001389629618	7	298
cell fate commitment	0.005578418322699365	5	118
regulation of cell-cell adhesion mediated by cadherin	0.005768878063985213	3	19
cell-cell adhesion mediated by cadherin	0.005768878063985213	3	19
response to decreased oxygen levels	0.006315835115030927	6	208
gene silencing	0.006315835115030927	6	208
vascular associated smooth muscle cell differentiation	0.006363847490790575	3	20
cardiac septum development	0.006363847490790575	4	60
vasculogenesis	0.0072717453535966325	3	21
negative regulation of cell population proliferation	0.007721986490512258	6	222
response to oxygen levels	0.007721986490512258	6	220
apical part of cell	0.007721986490512258	6	221
negative regulation of cell-cell adhesion	0.007721986490512258	5	130
negative regulation of gene expression, epigenetic	0.007721986490512258	4	65
atrioventricular valve development	0.007721986490512258	3	22
positive regulation of mitotic cell cycle	0.007721986490512258	4	64
cardiac epithelial to mesenchymal transition	0.007721986490512258	3	22
ERBB signaling pathway	0.007761558127105609	5	133
trabecula morphogenesis	0.00834260206781508	3	23
regulation of cell cycle G1/S phase transition	0.00926585625647936	5	139
negative regulation of biomineralization	0.00926585625647936	3	24
gland development	0.009411666963458307	5	140
endocardial cushion morphogenesis	0.010239904454357109	3	25
cell cycle G1/S phase transition	0.010634386437931834	6	239
reproductive system development	0.010765359642429157	5	146
regulation of endothelial cell migration	0.010765359642429157	5	147
positive regulation of cell cycle G1/S phase transition	0.010765359642429157	3	26
response to hypoxia	0.010765359642429157	5	147
reproductive structure development	0.010765359642429157	5	146
cellular response to decreased oxygen levels	0.010765359642429157	5	147
positive regulation of cell cycle phase transition	0.011278789388416775	4	75
regulation of epithelial to mesenchymal transition	0.01135369064353608	4	76
regulation of biomineral tissue development	0.01135369064353608	4	76
formation of primary germ layer	0.01135369064353608	4	76
regulation of biomineralization	0.01135369064353608	4	76
regulation of blood vessel endothelial cell migration	0.011820711267904257	4	77
aortic valve development	0.012295360318031712	3	28
epithelial cell migration	0.012948622541395314	6	255
endothelial cell differentiation	0.013957486446380247	4	81
cellular response to oxygen levels	0.014265917853919396	5	160
epithelium migration	0.014265917853919396	6	261
cardiocyte differentiation	0.014880213087449506	4	83
tissue migration	0.015517549699190275	6	266
sprouting angiogenesis	0.01600090757403375	4	85
heterotypic cell-cell adhesion	0.01699669943157262	3	32
negative regulation of transcription by RNA polymerase II	0.018476109191497933	3	33
regulation of DNA binding	0.018579403787838594	4	89
endothelial cell migration	0.01922596854076097	5	173
negative regulation of endothelial cell migration	0.020841686306089853	3	35
cardiac muscle tissue morphogenesis	0.020841686306089853	3	35
placenta development	0.020841686306089853	3	35
ventricular cardiac muscle tissue development	0.020841686306089853	3	35
muscle cell development	0.02260836080226634	4	95
regulation of cyclin-dependent protein serine/threonine kinase activity	0.024196427369309458	3	37
positive regulation of cell cycle	0.024829530107559592	6	296
regulation of transcription regulatory region DNA binding	0.027629031784147023	3	39
glial cell differentiation	0.027629031784147023	4	101
cardiac muscle tissue development	0.028196258260144214	4	102
chromatin organization involved in negative regulation of transcription	0.028196258260144214	4	102
endothelium development	0.028772590050368686	4	103
biomineral tissue development	0.028772590050368686	4	103
regulation of response to DNA damage stimulus	0.028946767740162114	5	194
visual system development	0.02915010805920685	5	195
regulation of cysteine-type endopeptidase activity	0.02915010805920685	5	195
negative regulation of cell adhesion	0.029603890494879676	5	196
biomineralization	0.02970503937802162	4	105
sensory system development	0.03052695881840389	5	198
muscle cell proliferation	0.03116904629858442	4	107
endoderm formation	0.03116904629858442	3	42
regulation of epithelial cell migration	0.033453190321414965	5	203
gastrulation	0.03411187275684693	4	110
chromatin organization involved in regulation of transcription	0.037388194619318124	4	113
muscle cell differentiation	0.037388194619318124	5	209
positive regulation of protein serine/threonine kinase activity	0.03962437242621868	5	212
regulation of G1/S transition of mitotic cell cycle	0.040520910255768434	4	116
DNA-templated transcription, initiation	0.04253409965124319	5	216
ossification	0.044042969885635955	5	218
heart valve formation	0.046331796060404516	2	10
lymphoid progenitor cell differentiation	0.046331796060404516	2	10
endoderm development	0.05098758809801486	3	51
peptidyl-tyrosine phosphorylation	0.05112263816903717	5	227
muscle organ development	0.05112263816903717	4	125
negative regulation of epithelial cell migration	0.052832655122351635	3	52
negative regulation of glial cell differentiation	0.05334536418083359	2	11
regulation of fatty acid beta-oxidation	0.05334536418083359	2	11
regulation of phospholipase A2 activity	0.05334536418083359	2	11
somitogenesis	0.05334536418083359	2	11
histone methyltransferase activity	0.05356745255327208	3	53
phosphatidylinositol-mediated signaling	0.05356745255327208	4	128
cell proliferation involved in heart morphogenesis	0.061740476740826	2	12
regulation of glial cell proliferation	0.061740476740826	2	12
camera-type eye morphogenesis	0.061740476740826	3	56
negative regulation of cell migration	0.06334853030933031	4	135
endocrine system development	0.06754610544505256	3	58
gliogenesis	0.06978404612392901	4	139
sensory organ development	0.06997255810861208	5	249
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	0.06997255810861208	2	13
regulation of astrocyte differentiation	0.06997255810861208	2	13
histone methyltransferase complex	0.07220369280748459	3	60
peptidyl-tyrosine modification	0.0727176966692394	5	252
positive regulation of growth	0.0727176966692394	4	142
positive regulation of mitotic cell cycle phase transition	0.0743462413455954	3	61
chromatin binding	0.07567349233841987	4	144
negative regulation of cysteine-type endopeptidase activity	0.07651650725829452	3	62
RNA polymerase II cis-regulatory region sequence-specific DNA binding	0.07651650725829452	3	62
negative regulation of blood vessel endothelial cell migration	0.07696659596967638	2	14
aldehyde dehydrogenase [NAD(P)+] activity	0.07696659596967638	2	14
regulation of gene expression, epigenetic	0.07725156473310618	4	146
regulation of oligodendrocyte differentiation	0.08668064944185185	2	15
regulation of binding	0.08668064944185185	5	266
coronary vasculature development	0.08668064944185185	2	15
G1/S transition of mitotic cell cycle	0.08767988396402292	4	152
regulation of endopeptidase activity	0.09159311391033502	5	270
ventricular cardiac muscle tissue morphogenesis	0.09526464389095285	2	16
glial cell proliferation	0.09526464389095285	2	16
positive regulation of collagen metabolic process	0.09526464389095285	2	16
cardioblast differentiation	0.09526464389095285	2	16